James Graham Brown Cancer Center, Division of Medical Oncology & Hematology, Department of Medicine, University of Louisville, Louisville, KY, USA.
Adv Exp Med Biol. 2020;1223:129-153. doi: 10.1007/978-3-030-35582-1_7.
Sphingosine-1-phosphate (S1P), together with other phosphosphingolipids, has been found to regulate complex cellular function in the tumor microenvironment (TME) where it acts as a signaling molecule that participates in cell-cell communication. S1P, through intracellular and extracellular signaling, was found to promote tumor growth, angiogenesis, chemoresistance, and metastasis; it also regulates anticancer immune response, modulates inflammation, and promotes angiogenesis. Interestingly, cancer cells are capable of releasing S1P and thus modifying the behavior of the TME components in a way that contributes to tumor growth and progression. Therefore, S1P is considered an important therapeutic target, and several anticancer therapies targeting S1P signaling are being developed and tested in clinics.
鞘氨醇-1-磷酸(S1P)与其他磷酸鞘脂一起,被发现调节肿瘤微环境(TME)中的复杂细胞功能,作为一种信号分子参与细胞间通讯。S1P 通过细胞内和细胞外信号,促进肿瘤生长、血管生成、化疗耐药和转移;它还调节抗肿瘤免疫反应,调节炎症,促进血管生成。有趣的是,癌细胞能够释放 S1P,从而改变 TME 成分的行为,促进肿瘤生长和进展。因此,S1P 被认为是一个重要的治疗靶点,几种针对 S1P 信号的抗癌疗法正在临床开发和测试中。